• 24 Jul 20

Benchmark Holdings' Peter George says sale of its vaccine facility is a 'win-win-win'

Benchmark Holdings' Peter George says sale of its vaccine facility is a 'win-win-win'

Benchmark Holdings Plc | BHCCF | 0 0 0%

    • 82 views

 

Benchmark Holdings PLC's (LON:BMK) chairman Peter George speaks to Proactive London's Andrew Scott soon after agreeing to sell its vaccine manufacturing assets at its facility in Braintree, UK to Cell and Gene Therapy Catapult. George says he's pleased that Benchmark has been able to be part of the UK solution for vaccine manufacturing.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Benchmark Holdings - Investor Presentation (Interim Results) - 12th June 2025

Companies: Benchmark Holdings Plc

Benchmark Holdings (BMK) Investor presentation April 2018

Companies: Benchmark Holdings Plc

Benchmark Holdings - Investor Presentation (Q1 Results) video recording - 28 February 2025

Companies: Benchmark Holdings Plc

Benchmark (BMK) FY20 results analyst presentation

Companies: Benchmark Holdings Plc

Benchmark Holdings: FY Results investor presentation - 12th December 2024

Companies: Benchmark Holdings Plc

Benchmark Holdings focused on making core business 'commercially profitable'

Companies: Benchmark Holdings Plc

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top